The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

GSK (GSK) announced that the European Medicines Agency, EMA, has accepted for review the regulatory application of a prefilled syringe ...

Influenza Vaccines Market is estimated to valued at USD 8.30 Bn in 2024 and is expected to reach USD 13.43 Bn by 2031, exhibiting CAGR of 7.1% from 2024-2031 BURLINGAME, CA, UNITED STATES ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. A health professional is seen vaccinating a person. STOCK PHOTO/Adobe Stock Nearly half ...

Additionally, just 44.5% of adults ages 75 and older have received the RSV vaccine, according to CDC data. Nearly half of all children are vaccinated against the flu at 42.9%, but just 11% have ...

(WLUK) -- Wisconsin health officials confirmed the first pediatric influenza-associated death in the state for the 2024-2025 season. "We are saddened to announce the season's first death of a ...

The Washington DOH recommends a yearly flu vaccine for everyone aged six months and older, including those who are pregnant. DOH recommends RSV vaccines for older adults and those who are pregnant.

Unfortunately, there's already a lot of competition in the RSV vaccine space. Moderna's mRESVIA must contend with Abrysvo from Pfizer and Arexvy from GSK. Both competing vaccines had nearly a ...